id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ffhd-74	Burnett, Bruce P.; Levy, Robert M.	Flavocoxid (Limbrel ®) manages osteoarthritis through modification of multiple inflammatory pathways: a review	2012		.htm	text/html	579	14	15	Flavocoxid (Limbrel ®) manages osteoarthritis through modification of multiple inflammatory pathways: a review | Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007 Skip to main content Skip to main navigation menu Skip to site footer Open Menu Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007 Home Food Science Publisher Functional Food Center Current Archives About About the Journal Aims and Scope Contact Editing Services Editorial Team Express Peer Review Graphical Abstract Journal Insights Privacy Statement Submissions Announcements Search Search Register Login Home / Archives / Vol. 2 No. 11 (2012): November 2012 / Review Articles Flavocoxid (Limbrel ®) manages osteoarthritis through modification of multiple inflammatory pathways: a review Authors Bruce P. Burnett Primus Pharmaceuticals, Inc., 4725 N. Scottsdale Road, Suite 200, Scottsdale, AZ 85251 Robert M. Levy Primus Pharmaceuticals, Inc., 4725 N. Scottsdale Road, Suite 200, Scottsdale, AZ 85251 DOI: https://doi.org/10.31989/ffhd.v2i11.74 Abstract Limbrel (flavocoxid) is marketed as an FDA-regulated medical food for the clinical dietary management of osteoarthritis (OA) to be used under physician supervision.	cache/ffhd-74.htm	txt/ffhd-74.txt